| Literature DB >> 33514726 |
Xin Hu1, Marcos R Estecio2,3, Runzhe Chen4, Alexandre Reuben4, Linghua Wang1, Junya Fujimoto5, Jian Carrot-Zhang6,7,8, Nicholas McGranahan9, Lisha Ying10,11, Junya Fukuoka12, Chi-Wan Chow5, Hoa H N Pham12, Myrna C B Godoy13, Brett W Carter13, Carmen Behrens4,5, Jianhua Zhang1, Mara B Antonoff14, Boris Sepesi14, Yue Lu2,3, Harvey I Pass15, Humam Kadara5, Paul Scheet16, Ara A Vaporciyan14, John V Heymach4, Ignacio I Wistuba4,5, J Jack Lee17, P Andrew Futreal18, Dan Su19, Jean-Pierre J Issa20, Jianjun Zhang21,22.
Abstract
The evolution of DNA methylome and methylation intra-tumor heterogeneity (ITH) during early carcinogenesis of lung adenocarcinoma has not been systematically studied. We perform reduced representation bisulfite sequencing of invasive lung adenocarcinoma and its precursors, atypical adenomatous hyperplasia, adenocarcinoma in situ and minimally invasive adenocarcinoma. We observe gradual increase of methylation aberrations and significantly higher level of methylation ITH in later-stage lesions. The phylogenetic patterns inferred from methylation aberrations resemble those based on somatic mutations suggesting parallel methylation and genetic evolution. De-convolution reveal higher ratio of T regulatory cells (Tregs) versus CD8 + T cells in later-stage diseases, implying progressive immunosuppression with neoplastic progression. Furthermore, increased global hypomethylation is associated with higher mutation burden, copy number variation burden and AI burden as well as higher Treg/CD8 ratio, highlighting the potential impact of methylation on chromosomal instability, mutagenesis and tumor immune microenvironment during early carcinogenesis of lung adenocarcinomas.Entities:
Year: 2021 PMID: 33514726 DOI: 10.1038/s41467-021-20907-z
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919